You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 9,623,022

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 9,623,022 protect, and when does it expire?

Patent 9,623,022 protects OLYSIO and is included in one NDA.

This patent has sixty-two patent family members in forty-one countries.

Summary for Patent: 9,623,022

Title:	Macrocyclic inhibitors of hepatitis C virus
Abstract:	Inhibitors of HCV replication of formula (I) ##STR00001## and the N-oxides, salts, and stereoisomers, wherein each dashed line represents an optional double bond; X is N, CH and where X bears a double bond it is C; R.sup.1 is --OR.sup.7, --NH--SO.sub.2R.sup.8; R.sup.2 is hydrogen, and where X is C or CH, R.sup.2 may also be C.sub.1-6alkyl; R.sup.3 is hydrogen, C.sub.1-6alkyl, C.sub.1-6alkoxyC.sub.1-6alkyl, C.sub.3-7cycloalkyl; R.sup.4 is aryl or Het; n is 3, 4, 5, or 6; R.sup.5 is halo, C.sub.1-6alkyl, hydroxy, C.sub.1-6alkoxy, phenyl, or Het; R.sup.6 is C.sub.1-6alkoxy, or dimethylamino; R.sup.7 is hydrogen; aryl; Het; C.sub.3-7cycloalkyl optionally substituted with C.sub.1-6alkyl; or C.sub.1-6alkyl optionally substituted with C.sub.3-7cycloalkyl, aryl or with Het; R.sup.8 is aryl; Het; C.sub.3-7cycloalkyl optionally substituted with C.sub.1-6alkyl; or C.sub.1-6alkyl optionally substituted with C.sub.3-7cycloalkyl, aryl or with Het; aryl is phenyl optionally substituted with one, two or three substituents; Het is a 5 or 6 membered saturated, partially unsaturated or completely unsaturated heterocyclic ring containing 1 to 4 heteroatoms selected from nitrogen, oxygen and sulfur, and being optionally substituted with one, two or three substituents; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I). Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.
Inventor(s):	Simmen; Kenneth Alan (Tervuren, BE), De Kock; Herman Augustinus (Arendonk, BE), Raboisson; Pierre Jean-Marie Bernard (Sterrebeek, BE), Hu; Lili (Mechelen, BE), Tahri; Abdellah (Anderlecht, BE), Surleraux; Dominique Louis Nestor Ghislain (Braine-le-chateau, BE), Nilsson; Karl Magnus (Gothenburg, SE), Samuelsson; Bengt Bertil (Skarholmen, SE), Rosenquist; .ANG.sa Annica Kristina (Huddinge, SE), Ivanov; Vladimir (Moscow, RU), Pelcman; Mikael (Alvsjo, SE), Belfrage; Anna Karin (Uppsala, SE), Johansson; Per-Ola Mikael (Huddinge, SE), Vendeville; Sandrine Marie Helene (Etterbeek, BE)
Assignee:	Janssen Sciences Ireland UC (Little Island, Co. Cork, IE) Medivir AB (Huddinge, SE)
Application Number:	15/137,997
Patent Claim Types: see list of patent claims	Use;
Patent landscape, scope, and claims:	Analyzing the Scope and Claims of United States Patent 9,623,022: A Comprehensive Guide Introduction Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 9,623,022, providing a thorough analysis of its claims, scope, and the broader patent landscape. Identifying the Patent To begin, it is essential to identify the patent in question. United States Patent 9,623,022 can be found through the USPTO's Patent Public Search tool or other patent databases such as those provided by the European Patent Office (EPO) or the World Intellectual Property Organization (WIPO)[1]. Understanding Patent Claims Patent claims are the heart of any patent, defining the scope of the invention and what is protected by the patent. The Patent Claims Research Dataset provided by the USPTO can offer insights into claim structures and dependencies, which can be applied to understanding the claims of US Patent 9,623,022[4]. Independent and Dependent Claims Independent Claims: These claims stand alone and define the invention without reference to other claims. They are critical in determining the scope of the patent. Dependent Claims: These claims refer back to and further limit the independent claims. They often add specific details or features to the invention. Claim Analysis For US Patent 9,623,022, one would need to review each claim carefully: Identify the independent claims to understand the core invention. Analyze dependent claims to see how they narrow down the scope. Consider the claim language, ensuring clarity on what is protected and what is not. Scope of the Patent The scope of a patent is determined by its claims and the description provided in the specification. Specification and Drawings The specification and drawings of the patent provide context and details about the invention. These sections help in understanding how the claimed invention works and its various embodiments. Prior Art and Novelty To assess the scope, one must also consider prior art cited during the patent prosecution process. The Common Citation Document (CCD) can be useful in consolidating prior art citations from multiple offices, helping to understand the novelty and non-obviousness of the invention[1]. Patent Landscape Analysis Understanding the broader patent landscape is essential for strategic decision-making. Patent Family Using tools like the Global Dossier, one can identify the patent family for US Patent 9,623,022. This includes related applications filed at participating IP Offices, along with dossier, classification, and citation data[1]. Competitor Patents Searching international patent offices and databases such as esp@cenet (EPO), PATENTSCOPE (WIPO), and others can reveal competitor patents in the same field. This helps in identifying potential infringement risks and opportunities for collaboration or licensing[1]. Legal Considerations Legal considerations are vital in patent analysis. Obviousness-Type Double Patenting (ODP) The Federal Circuit's decisions, such as in the case of In re Cellect, highlight the importance of ODP analysis. This ensures that an inventor does not secure multiple patents for the same invention with different expiration dates due to Patent Term Adjustments (PTA)[5]. Patent Term Adjustments (PTA) Understanding how PTA affects the patent term is crucial. The USPTO's rules on PTA, as outlined in cases like In re Cellect, can impact the effective term of the patent and its family members[5]. Practical Applications and Strategies Licensing and Collaboration Analyzing the scope and claims can help in identifying potential licensing opportunities or collaborations. Knowing what is protected and what is not can facilitate negotiations. Infringement Analysis Conducting an infringement analysis involves comparing the claims of the patent with the features of potentially infringing products or processes. This is a critical step in enforcing patent rights. Tools and Resources for Patent Search USPTO Resources The USPTO provides several tools, including the Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs), which are invaluable for conducting thorough patent searches[1]. International Databases Accessing international databases such as those from the EPO, JPO, and WIPO can provide a global perspective on the patent landscape[1]. Expert Insights and Best Practices Consult with Experts Consulting with patent attorneys and experts, such as those involved in the ACUS study on small claims patent courts, can provide valuable insights into the legal and practical aspects of patent claims and scope[2]. Training and Education Utilizing resources like the USPTO's Web Based Tutorial on conducting preliminary U.S. patent searches can enhance one's skills in patent analysis[1]. Key Takeaways Claims Analysis: Carefully review independent and dependent claims to understand the scope of the patent. Patent Landscape: Use tools like Global Dossier and international databases to identify related patents and competitors. Legal Considerations: Understand ODP and PTA to ensure compliance with patent laws. Practical Applications: Use patent analysis for licensing, collaboration, and infringement analysis. Resources: Leverage USPTO and international resources for comprehensive patent searches. FAQs What is the importance of independent claims in a patent? Independent claims define the core invention and are crucial in determining the scope of the patent. How can I identify related patents globally? Use the Global Dossier and international patent databases like esp@cenet and PATENTSCOPE to identify related patents. What is Obviousness-Type Double Patenting (ODP)? ODP prevents an inventor from securing multiple patents for the same invention with different expiration dates, ensuring that the patent term is not extended unfairly. How do Patent Term Adjustments (PTA) affect the patent term? PTA can extend the patent term due to delays in the USPTO's processing, but it does not extend the term past the date of a terminal disclaimer. What resources are available for training in patent search techniques? The USPTO offers a Web Based Tutorial and training through Patent and Trademark Resource Centers (PTRCs). Sources USPTO - Search for patents: https://www.uspto.gov/patents/search ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court Justia Patents - Lili Hu Inventions: https://patents.justia.com/inventor/lili-hu?page=2 USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset United States Court of Appeals for the Federal Circuit - In re Cellect: https://cafc.uscourts.gov/opinions-orders/22-1293.OPINION.8-28-2023_2181381.pdf More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 9,623,022

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Janssen Prods	OLYSIO	simeprevir sodium	CAPSULE;ORAL	205123-001	Nov 22, 2013		DISCN	Yes	No	9,623,022	⤷ Subscribe				METHOD OF TREATING HEPATITIS C	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,623,022

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1912999	⤷ Subscribe	CA 2014 00053	Denmark	⤷ Subscribe
European Patent Office	1912999	⤷ Subscribe	C300697	Netherlands	⤷ Subscribe
European Patent Office	1912999	⤷ Subscribe	PA2014036	Lithuania	⤷ Subscribe
European Patent Office	1912999	⤷ Subscribe	1490062-5	Sweden	⤷ Subscribe
European Patent Office	1912999	⤷ Subscribe	14C0076	France	⤷ Subscribe
European Patent Office	1912999	⤷ Subscribe	C20140034 00151	Estonia	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.